Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

The Warehouse Group Limited Director's Dealing 2021

Oct 5, 2021

66302_rns_2021-10-05_cdc6fc22-1a8c-428b-9649-5b529c43e1aa.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [84 x 23] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ble)
N/A
N/A
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
N/A
A statement as to whether the derivative is cash settled orphysicallysettled: N/A
Maturitydate of the derivative(if any): N/A
Expirydate of the derivative(if any): N/A
Theprice specified in the terms of the derivative(if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Date of transaction: (a) 1 October 2021
(b) 5 October 2021
Nature of transaction: (a) On-market purchase of 25,576 shares
(b) On-market purchase of 24,424shares
Name of anyotherpartyorparties to the transaction(if known): N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:
(a) $103,327.04 (25,576 shares at $4.04 per share)
(b) $100,138.40 (24,424 shares at $4.10 per share)
Number of financial products to which the transaction related: (a) 25,576
(b)24,424
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed duringthe closedperiod:
N/A
Date of theprior written clearance(if any): N/A
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
N/A
N/A
N/A
N/A
N/A
The notional value of the derivative (if any) or the notional amount of underlying financial
products(if any):
N/A
A statement as to whether the derivative is cash settled orphysicallysettled: N/A
Maturitydate of the derivative(if any): N/A
Expirydate of the derivative(if any): N/A
Theprice's specified terms(if any): N/A
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
N/A
Parties to the derivative: N/A
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
N/A
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature ofperson authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorisedperson:
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature ofperson authorised to sign on behalf of director or officer:
Date of signature: 5 October 2021
Name and title of authorisedperson: Erin Vercoe,CompanySecretary